The problem of treating AML with CD123-targeting drugs

As diseases mutate our knowledge of them increases. In this interview, Prof. John DiPersio, MD, PhD from Washington University School of Medicine, Washington, WA explains how the low number of mutatio... Author: VJHemOnc Added: 11/23/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts